NDC 0527-2430 – Bupropion hydrochloride (XL)
Bupropion Hydrochloride 300 mg/1 · Tablet, Extended Release · Oral
Product NDC0527-2430
Product details
- Brand name
- Bupropion hydrochloride (XL)
- Generic name
- Bupropion hydrochloride
- Labeler
- Lannett Company Inc.
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA208652
- Marketed since
- January 8, 2018
- Listing expires
- December 31, 2027
- Pharmacologic class
- Aminoketone
Active ingredients
- Bupropion Hydrochloride 300 mg/1
Uses, dosage, side effects and warnings for Bupropion Hydrochloride (XL) →
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 0527-2430-32 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2430-32) | Jan 31, 2022 |
| 0527-2430-41 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2430-41) | Jan 31, 2022 |
| 0527-2430-43 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2430-43) | Jan 31, 2022 |
| 0527-2430-46 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2430-46) | Jan 31, 2022 |
Other Bupropion Hydrochloride (XL) products
- 62135-875 Bupropion Hydrochloride 150 mg/1 · Tablet, Extended Release · Chartwell RX, LLC
- 62135-876 Bupropion Hydrochloride 300 mg/1 · Tablet, Extended Release · Chartwell RX, LLC
- 0527-2415 Bupropion Hydrochloride 150 mg/1 · Tablet, Extended Release · Lannett Company Inc.
- 83301-0024 Bupropion Hydrochloride 150 mg/1 · Tablet, Extended Release · Mullan Pharmaceutical Inc.
- 83301-0025 Bupropion Hydrochloride 300 mg/1 · Tablet, Extended Release · Mullan Pharmaceutical Inc.
- 69680-157 Bupropion Hydrochloride 150 mg/1 · Tablet, Extended Release · Vitruvias Therapeutics
- 69680-158 Bupropion Hydrochloride 300 mg/1 · Tablet, Extended Release · Vitruvias Therapeutics